Prashant
2021-10-26
This approval will embark the commencement of new era for Indian Pharma sector .
Ocugen stock surged 33% in extended trading<blockquote>Ocugen股价在盘后交易中飙升33%</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
3
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":856552243,"tweetId":"856552243","gmtCreate":1635204497698,"gmtModify":1635204525065,"author":{"id":3569291088297790,"idStr":"3569291088297790","authorId":3569291088297790,"authorIdStr":"3569291088297790","name":"Prashant","avatar":"https://static.tigerbbs.com/d8814671cf4887208a8404f7fc63d9fd","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":18,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>This approval will embark the commencement of new era for Indian Pharma sector .</p><p><br></p></body></html>","htmlText":"<html><head></head><body><p>This approval will embark the commencement of new era for Indian Pharma sector .</p><p><br></p></body></html>","text":"This approval will embark the commencement of new era for Indian Pharma sector .","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/856552243","repostId":1134394285,"repostType":4,"repost":{"id":"1134394285","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635204261,"share":"https://www.laohu8.com/m/news/1134394285?lang=zh_CN&edition=full","pubTime":"2021-10-26 07:24","market":"us","language":"en","title":"Ocugen stock surged 33% in extended trading<blockquote>Ocugen股价在盘后交易中飙升33%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1134394285","media":"Tiger Newspress","summary":"Ocugen stock surged 33% in extended trading as the WHO expert group will meet on Tuesday to approve ","content":"<p>Ocugen stock surged 33% in extended trading as the WHO expert group will meet on Tuesday to approve EUA of COVID-19 vaccine covaxin in cooperation with India.</p><p><blockquote>Ocugen股价在盘后交易中飙升33%，因世卫组织专家组将于周二召开会议，批准与印合作的新冠疫苗科瓦克辛EUA。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/75ccaedccac7e3cc601730bb5fa6da04\" tg-width=\"849\" tg-height=\"617\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Ocugen shares are rising in the post-market ahead of a meeting by an advisory panel of The World Health Organisation (WHO) on Tuesday to discuss whether to grant an emergency use listing for its partner’s COVID-19 vaccine named Covaxin.</p><p><blockquote>周二，世界卫生组织(WHO)顾问小组召开会议，讨论是否批准其合作伙伴的COVID-19疫苗科瓦克辛紧急使用清单，随后Ocugen股价在盘后上涨。</blockquote></p><p> WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group.</p><p><blockquote>世卫组织将根据技术咨询小组的建议，对巴拉特生物技术公司研发的疫苗做出决定。</blockquote></p><p> Social media is abuzz with speculation that the WHO has already greenlighted the vaccine as the global body has posted on its website several documents related to the vaccine ahead of the meeting.</p><p><blockquote>社交媒体上充斥着这样的猜测，即世卫组织已经为该疫苗开了绿灯，因为该全球机构在会议前在其网站上发布了几份与疫苗相关的文件。</blockquote></p><p> Ocugen (OCGN) partnered with Bharat Biotech to co-develop Covaxin for the U.S. market, and in late-stage trials, it has shown about 78% efficacy against COVID-19.</p><p><blockquote>Ocugen(OCGN)与Bharat Biotech合作，共同开发面向美国市场的科瓦克辛，在后期试验中，其对COVID-19的疗效约为78%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen stock surged 33% in extended trading<blockquote>Ocugen股价在盘后交易中飙升33%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen stock surged 33% in extended trading<blockquote>Ocugen股价在盘后交易中飙升33%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-10-26 07:24</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Ocugen stock surged 33% in extended trading as the WHO expert group will meet on Tuesday to approve EUA of COVID-19 vaccine covaxin in cooperation with India.</p><p><blockquote>Ocugen股价在盘后交易中飙升33%，因世卫组织专家组将于周二召开会议，批准与印合作的新冠疫苗科瓦克辛EUA。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/75ccaedccac7e3cc601730bb5fa6da04\" tg-width=\"849\" tg-height=\"617\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Ocugen shares are rising in the post-market ahead of a meeting by an advisory panel of The World Health Organisation (WHO) on Tuesday to discuss whether to grant an emergency use listing for its partner’s COVID-19 vaccine named Covaxin.</p><p><blockquote>周二，世界卫生组织(WHO)顾问小组召开会议，讨论是否批准其合作伙伴的COVID-19疫苗科瓦克辛紧急使用清单，随后Ocugen股价在盘后上涨。</blockquote></p><p> WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group.</p><p><blockquote>世卫组织将根据技术咨询小组的建议，对巴拉特生物技术公司研发的疫苗做出决定。</blockquote></p><p> Social media is abuzz with speculation that the WHO has already greenlighted the vaccine as the global body has posted on its website several documents related to the vaccine ahead of the meeting.</p><p><blockquote>社交媒体上充斥着这样的猜测，即世卫组织已经为该疫苗开了绿灯，因为该全球机构在会议前在其网站上发布了几份与疫苗相关的文件。</blockquote></p><p> Ocugen (OCGN) partnered with Bharat Biotech to co-develop Covaxin for the U.S. market, and in late-stage trials, it has shown about 78% efficacy against COVID-19.</p><p><blockquote>Ocugen(OCGN)与Bharat Biotech合作，共同开发面向美国市场的科瓦克辛，在后期试验中，其对COVID-19的疗效约为78%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134394285","content_text":"Ocugen stock surged 33% in extended trading as the WHO expert group will meet on Tuesday to approve EUA of COVID-19 vaccine covaxin in cooperation with India.\n\nOcugen shares are rising in the post-market ahead of a meeting by an advisory panel of The World Health Organisation (WHO) on Tuesday to discuss whether to grant an emergency use listing for its partner’s COVID-19 vaccine named Covaxin.\nWHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group.\nSocial media is abuzz with speculation that the WHO has already greenlighted the vaccine as the global body has posted on its website several documents related to the vaccine ahead of the meeting.\nOcugen (OCGN) partnered with Bharat Biotech to co-develop Covaxin for the U.S. market, and in late-stage trials, it has shown about 78% efficacy against COVID-19.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":610,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":67,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/856552243"}
精彩评论